Suppr超能文献

抗 Bm86 和 Subolesin 抗体的组合可抑制 Rhipicephalus australis(以前称为 Rhipicephalus microplus)幼虫在体外的饱血。

A combination of antibodies against Bm86 and Subolesin inhibits engorgement of Rhipicephalus australis (formerly Rhipicephalus microplus) larvae in vitro.

机构信息

Center for Experimental and Molecular Medicine, Amsterdam Infection & Immunity, Amsterdam UMC, Univ of Amsterdam, Meibergdreef 9, 1105AZ, Amsterdam, The Netherlands.

Mérieux NutriSciences, Pascalstraat 25, 6716 AZ, Ede, The Netherlands.

出版信息

Parasit Vectors. 2019 Jul 25;12(1):362. doi: 10.1186/s13071-019-3616-3.

Abstract

BACKGROUND

Rhipicephalus microplus is a hard tick species that has a high impact on cattle health and production in tropical and subtropical regions. Recently, ribosomal DNA and morphological analysis resulted in the reinstatement of R. australis as a separate species from R. microplus. Both feed on cattle and can transmit bovine pathogens such as Anaplasma and Babesia species. The current treatment with acaricides is becoming increasingly less effective due to the emergence of resistant tick strains. A promising alternative can be found in the form of anti-tick vaccines. The available commercial vaccines can be used to control tick infestation, but the lack of a knockdown effect (> 90% reduction in tick numbers as seen with effective acaricides) hampers its widespread use, hence higher efficacious vaccines are needed. Instead of searching for new protective antigens, we investigated the efficacy of vaccines that contain more than one (partially) protective antigen. For screening vaccine formulations, a previously developed in vitro feeding assay was used in which R. australis larvae are fed sera that were raised against the candidate vaccine antigens. In the present study, the efficacy of the Bm86 midgut antigen and the cytosolic Subolesin (SUB) antigen were evaluated in vitro.

RESULTS

Antiserum against recombinant Bm86 (rBm86) partially inhibited larval engorgement, whereas antiserum against recombinant SUB (rSUB) did not have any effect on feeding of larvae. Importantly, when larvae were fed a combination of antiserum against rBm86 and rSUB, a synergistic effect on significantly reducing larval infestations was found. Immunohistochemical analysis revealed that the rBm86 antiserum reacted with gut epithelium of R. australis larvae, whereas the antiserum against rSUB stained salivary glands and rectal sac epithelium.

CONCLUSIONS

Combining anti-Bm86 and anti-subolesin antibodies synergistically reduced R. australis larval feeding in vitro. Rhipicephalus australis is a one host tick, meaning that the larvae develop to nymphs and subsequently adults on the same host. Hence, this protective effect could be even more pronounced when larvae are used for infestation of vaccinated cattle, as the antibodies could then affect all three developmental stages. This will be tested in future in vivo experiments.

摘要

背景

璃眼蜱属的 Rhipicephalus microplus 是一种硬蜱,对热带和亚热带地区的牛的健康和生产有很大影响。最近,核糖体 DNA 和形态分析结果表明,R. australis 从 R. microplus 中重新被确认为一个独立的物种。两者都以牛为食,并能传播牛病原体,如无形体和巴贝斯虫。由于抗蜱菌株的出现,目前使用杀蜱剂的治疗效果越来越差。一种有希望的替代方法是抗蜱疫苗。现有的商业疫苗可用于控制蜱的侵染,但缺乏击倒效果(与有效杀蜱剂相比,减少 90%以上的蜱数量),限制了其广泛使用,因此需要更高有效的疫苗。我们没有寻找新的保护性抗原,而是研究了含有一种以上(部分)保护性抗原的疫苗的效果。为了筛选疫苗配方,我们使用了以前开发的体外喂养试验,在该试验中,用针对候选疫苗抗原的血清喂养 R. australis 幼虫。在本研究中,评估了 Bm86 中肠抗原和胞质 Subolesin (SUB) 抗原的体外功效。

结果

针对重组 Bm86(rBm86)的抗血清部分抑制了幼虫的吸血,而针对重组 SUB(rSUB)的抗血清对幼虫的取食没有任何影响。重要的是,当幼虫同时喂食针对 rBm86 和 rSUB 的抗血清时,发现对显著减少幼虫侵染有协同作用。免疫组织化学分析显示,rBm86 抗血清与 R. australis 幼虫的肠上皮反应,而针对 rSUB 的抗血清则染色唾液腺和直肠囊上皮。

结论

联合使用抗 Bm86 和抗 subolesin 抗体可协同减少 R. australis 幼虫的体外取食。Rhipicephalus australis 是一种一宿主蜱,这意味着幼虫在同一宿主上发育为若虫,然后发育为成虫。因此,当幼虫用于感染接种疫苗的牛时,这种保护作用可能更为明显,因为抗体可以影响所有三个发育阶段。这将在未来的体内实验中进行测试。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec39/6657053/3caa031d79d9/13071_2019_3616_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验